Shopping Cart
- Remove All
- Your shopping cart is currently empty
Claudin-6 Protein, Human, Recombinant, Fluorescent,VLP is expressed in HEK293 mammalian cells. The predicted molecular weight is 50.31 kDa and the accession number is P56747.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
20 μg | $838 | 7-10 days | |
100 μg | $1,670 | 7-10 days | |
500 μg | $5,310 | 7-10 days |
Biological Activity | Immobilized Human CLDN6-VLP (Full Length) Protein at 5 μg/mL (100 μL/well) can bind Anti-Human CLDN6 Antibody, Human IgG1, the EC50 is 5-25 ng/mL. |
Description | Claudin-6 Protein, Human, Recombinant, Fluorescent,VLP is expressed in HEK293 mammalian cells. The predicted molecular weight is 50.31 kDa and the accession number is P56747. |
Species | Human |
Expression System | HEK293 Cells |
Tag | Tag Free |
Accession Number | P56747 |
Synonyms | claudin 6 |
Construction | A DNA sequence encoding the human CLDN6 (P56747) (Met1-Val220) was expressed. This protein carries a GFP tag. Predicted N terminal: Met 1 |
Molecular Weight | 50.31 kDa (predicted) |
Endotoxin | < 1.0 EU/μg of the protein as determined by the LAL method. |
Formulation | Supplied as solution in 50 mM HEPES, 150 mM NaCI, 10% Trehalose, pH 7.2. |
Stability & Storage | It is recommended to store the product under sterile conditions at -70°C or lower. Samples are stable for up to 12 months at -80°C. Please avoid multiple freeze-thaw cycles and store products in aliquots. |
Shipping | Shipping with blue ice. |
Research Background | Claudin-6 (CLDN6) belongs to the claudins family and is a transmembrane protein found in tight junctions with two extracellular loops and intracellular N and C tails. CLDN6 modulates the ion- and charge-specific permeability of the paracellular pathway in most epithelial tissues. It regulates the paracellular flux of cations in the kidney through forming heterotypic strands with other claudins and has a role in maintaining the lung epithelial barrier function. The CLDN6 gene is adjacent to another family member, CLDN9, on chromosome 16. Certain CLDN6-positive cancers, encompassing ovarian, endometrial, and testicular malignancies, have been shown to have their proliferation and invasiveness suppressed upon CLDN6 silencing. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.